Ancient heat therapy put to the test for menstrual cramps

NCT ID NCT07799285

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 02, 2026 · Last updated Sep 03, 2026 · Updated 1 time

Summary

This trial tests whether suspended moxibustion, a traditional therapy that holds a burning moxa stick near the skin, can reduce pain from primary dysmenorrhea, or period cramps without an underlying disease. Researchers plan to enroll 48 female students aged 18 to 35 who have moderate to severe period pain. Participants will receive daily 20-minute moxibustion sessions at three acupoints, starting a week before their period and continuing through it, for three cycles. The study measures changes in pain scores, symptom burden, and skin temperature to see if the therapy helps.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Suspended moxibustion, a traditional therapy where a burning moxa stick is held above the skin at acupoints CV4, CV8, and SP6
What this could lead to
If it works, moxibustion could offer a drug-free option for managing period pain and related symptoms like fatigue and headache.
What could go wrong
This is a small, single-arm study with no placebo group, so any pain relief could come from expectation rather than the therapy itself. Results may not apply beyond the specific student group studied.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

48 people

The number who actually took part.

Started

Dec 2025

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 35 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged 18-35 years with a regular menstrual cycle (28 ± 7 days) * History of moderate-to-severe dysmenorrhea (VAS ≥ 4) in at least 3 consecutive menstrual cycles prior to enrolment * Willing to participate and providing written informed consent Exclusion Criteria: * Secondary dysmenorrhea attributable to endometriosis, pelvic inflammatory disease, or uterine fibroids (confirmed by abdominal ultrasound) * Neurological disorders, immunodeficiency, or uncontrolled bleeding disorders * Any systemic medical condition contraindicating moxibustion * Use of prostaglandin synthesis inhibitors (PGSIs) within two weeks prior to enrolment * Pregnancy, lactation, or planned pregnancy within the following 6 months * Current use of NSAIDs or oral contraceptives * Ongoing or recent moxibustion treatment within 2 weeks prior to registration

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Primary dysmenorrhea are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Can Tho University of Medicine and Pharmacy

    Can Tho, Ninh Kieu, 94100, Vietnam

More trials for these conditions

Other studies related to the condition(s) this trial covers.